Weeks after telegraphing a series of upgrades to its Mexico operations over the next five years, Bayer is rolling up its ...

The advancement of Pfizer’s antibody-drug conjugate portfolio has not spared the former Seagen site—and those who helped ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

In May, radiopharmaceutical drug developer Ratio Therapeutics unveiled plans to build a new research and manufacturing plant ...